Home / Success Plan (Invoice-based) – Terms & Conditions
Success Plan (Invoice-based) – Terms & Conditions
By subscribing to the Success Plan (Invoice-based), you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Success Plan – Invoice-based you get:
Note: This service is provided on a non-exclusive basis. Introductions do not guarantee client responses, lead volume, or awarded projects.
Each time you receive a client payment, MAI CDMO issues an invoice for the applicable commission. Payment is due within 30 days of the invoice date, by bank transfer to the account provided on the invoice.
A “Client” means any company contacted through the MAI CDMO platform or promotional activities for a defined project and regulatory requirements analyzed by MAI CDMO.
Exception: If you can prove a pre-existing commercial relationship with the same client (by providing a formal proposal sent within the last 5 years for the same activity and regulatory requirements), the client will not be considered an introduced Client for fee purposes. If no such proof is provided, the Client will be deemed introduced by MAI CDMO, and fees will apply.
The initial term of the subscription shall be one (1) year. The subscription will automatically renew for additional one (1) year terms unless either party provides written notice or, through the platform (Account settings), its intention not to renew at least three (3) months prior to the expiration date.
2026-01-07
Pharmaron is a leading life sciences service provider, offering a wide range of research, development, and manufacturing capabilities across the entire drug discovery, preclinical, clinical development, and commercialization process.
See more
2025-11-05
Mabion is a CDMO company specializing in the advanced manufacturing and development of biological products, with extensive experience in monoclonal antibodies. Founded in 2007 and headquartered in the EU, in Poland.
See more
2025-10-15
Cultiply is a specialized biotechnology company dedicated to industrial microbiology and fermentation technologies for biological processes. This company is focused on offering a complete innovation platform, from the idea phase to industrial scaling.
See more
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Certifications: EMA (EU GMP)
Markets: EMA (EU)
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA...
Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: INVIMA (Colombia), FDA (USA), EMA (EU), MHRA (UK),...
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Commercial API Small Molecules Synthesis
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, FDA (cGMP), ECOVADIS
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
If you have any questions or suggestions, click here. We will be happy to assist you.
